Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation

Figure 5

Survival analysis and validation of the hub genes in AML. Survival analysis of ALDH1A1 (a) and CFD (b). Here, the blue dotted lines indicate the ranges of expression levels of low ALDH1A1 TPM and low CFD TPM, and the red dotted lines indicate the ranges of expression levels of high ALDH1A1 TPM and high CFD TPM. The verification of mRNA expression of ALDH1A1 (c) and CFD (d) in terms of the boxplots.

(a)

(b)

(c)

(d)